Jacky Gale

Since beginning her journalism career with a focus on the healthcare industry, Jacky has written extensively about the dangers of many popular medications, including Actos, Yaz, Xarelto and more.

Effexor Birth Defect Trials to Move Forward

December 9, 2014 By: Jacky Gale Antidepressants

Pharmaceutical giant Pfizer is currently facing at least 68 product liability lawsuits filed in the federal court system with regard to its medication, Effexor (venlafaxine). The Effexor lawsuits claim the drug causes birth defects. In August of 2013, federal Effexor lawsuits were centralized into a multidistrict litigation (MDL), which is... Read more »

Microbial Contamination Leads to Xarelto Recall

October 31, 2014 By: Jacky Gale Xarelto

The Janssen unit of Johnson & Johnson recently announced a Xarelto recall due to the discovery of a microbial contamination. To date, information regarding the exact nature of the contamination has not been released and so far it appears that no patients have suffered an illness because of the problem.... Read more »

Propecia Lawsuit Lists Cancer Among the Plaintiff’s Complications

September 17, 2014 By: Jacky Gale Propecia

Lawsuits have been piling up against Merck & Co. with regard to the defendants’ medication, Propecia (finasteride). The lawsuits typically claim that the drug is unreasonably dangerous and defective, and that it has caused severe side effects. Now, a Florida resident has filed a new Propecia lawsuit claiming breast cancer... Read more »

Bayer Settles Thousands of Yaz Lawsuits

August 12, 2014 By: Jacky Gale Yaz

Bayer Healthcare, a pharmaceutical giant, revealed the resolution of thousands of Yaz lawsuits in its second quarter financial report for 2014. The company and over 17,000 claimants agreed to a settlement of over $1.8 billion. The plaintiffs had sued Bayer with regard to life-threatening side effects that were allegedly caused... Read more »

$650 Million Settlement Reached for Thousands of Pradaxa Lawsuits

June 3, 2014 By: Jacky Gale Pradaxa

In a statement issued on May 28, 2014, the pharmaceutical giant Boehringer Ingelheim announced that they had reached a settlement agreement with plaintiffs who filed lawsuits with regard to side effects from Pradaxa, a medication designed and manufactured by the company. The Pradaxa settlement involves a payout of $650 million,... Read more »

Counsel for Takeda Pharmaceuticals Face Sanctions in Actos Trial

May 12, 2014 By: Jacky Gale Actos

The Actos trial proceeding in a Las Vegas courtroom recently resulted in some negative publicity for the defendants, Takeda Pharmaceuticals. The lawyers for the defendants were reprimanded by U.S. District Judge Kerry Earley for their unprofessional behavior and they now face sanctions imposed by the Judge. Since the trial began... Read more »